Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per specialist: Novartis
Woman and Man Max 99 years
Novartis
Update Il y a 5 ans
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Rheumatoid Arthritis With Ongoing Treatment With Methotrexate
This study assessed the long-term safety and tolerability of ACZ885 in patients with rheumatoid arthritis, as well as long-term efficacy, long-term preservation and/or improvement of joint...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Novartis Pharmaceuticals
Update Il y a 5 ans
Feasibility of Doctors' Rooms-based Infusion of Zoledronic Acid
1. The study will assess the safety and tolerability of a single-infusion of zoledronic acid 5 mg administered in a private medical practice setting by a nurse provided by a nati...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis
Update Il y a 5 ans
Effect of Severe Renal Impairment on Pharmacokinetics and Metabolism of a Single Administration of Licarbazepine
This study will assess the influence of severe renal impairment on the pharmacokinetics of licarbazepine and its glucuronide conjugate after single oral administration in healthy subjects ...
Country
Czech Republic
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis
Update Il y a 5 ans
Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension
This study will compare the safety and efficacy of once daily dosing of aliskiren to twice daily dosing of aliskiren in patients with moderate hypertension
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis
Update Il y a 5 ans
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic Fibrosis
This study will investigate the safety, tolerability, pharmacokinetic, and pharmacodynamic response of patients with cystic fibrosis to administration of QAU145 via intranasal spray.
Country
United States
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis
Update Il y a 5 ans
Safety, Tolerability, Effect of Vildagliptin and How the Body Changes the Blood Level of Vildagliptin in Healthy Chinese Volunteers
The purpose of this study is to assess the safety, tolerability, effect of vildagliptin and how the body changes the blood level of vildagliptin of single and multiple oral doses of vildag...
Country
China
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis
Update Il y a 5 ans
A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber
This study will compare the effectiveness of QAV680 against placebo in treating the symptoms of seasonal allergic rhinitis in an Environmental Exposure Chamber.
Country
Canada
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis
Update Il y a 5 ans
Effect of BGG492 on EEG in Patients With Photosensitive Epilepsy
This study will evaluate the efficacy of BGG492 in reducing the sensitivity to flashing lights of patients with photosensitive epilepsy, using EEG as a readout.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Pharmaceuticals, Japan
Update Il y a 5 ans
SPP100 Dose Finding Study in Japan
This study will evaluate the efficacy of SPP100 in lowering blood pressure in patients with essential hypertension.
Country
Japan
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis
Update Il y a 5 ans
Study to Evaluate the Efficacy, Safety, Tolerability and Immunogenicity of 100µg NIC002 Vaccine in Cigarette Smokers Who Are Motivated to Quit Smoking
This study is designed to determine the efficacy of high nicotine-specific antibody titers in smoking cessation.
Country
Germany
organs
None
Specialty
None
Closed trial
More information
Previous
1
2
3
4
5
6
7
8
9
10
Next